Personal Finance

2018 ASCO Conference Roundup

An aerial view of Chicago's skyline.

The annual American Society of Clinical Oncology Conference kicks off Friday, June 1, 2018.

Every year, thousands of healthcare professionals, scientists, and investors assemble in Chicago to hear about the latest scientific breakthroughs redefining cancer care. Over the course of this five-day conference, hundreds of companies -- including Celgene (NASDAQ: CELG) , Gilead Sciences (NASDAQ: GILD) , and Loxo Oncology (NASDAQ: LOXO) -- will be providing much-anticipated pipeline updates and plenty of market-moving news.

Not in Chicago? No worries! The Motley Fool's healthcare team has got you covered with all the latest headlines, announcements, and analysis. Be sure to check back on this page for updates!

An aerial view of Chicago's skyline.

Chicago, Illinois, home of the American Society of Clinical Oncology Conference. Image source: Getty Images.

10 stocks we like better than Loxo Oncology

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Loxo Oncology wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of May 8, 2018

Shannon Jones has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Celgene and Gilead Sciences. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GILD

Other Topics

Stocks

The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Learn More